Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
13 Feb 2009 04:23 PM
RNS
Holding(s) in Company
27 Jan 2009 10:46 AM
RNS
Result of AGM
13 Jan 2009 12:30 PM
RNS
Change of Registered Office
22 Dec 2008 02:47 PM
RNS
Publication of Report & Accou
22 Dec 2008 07:29 AM
RNS
Restoration of Listing
27 Nov 2008 02:44 PM
RNS
Final Results
16 Sep 2008 11:45 AM
RNS
End of Offer Period
29 Aug 2008 01:56 PM
RNS
Directorate Change and Update
26 Aug 2008 07:00 AM
RNS
Disposal
11 Jul 2008 05:59 PM
RNS
Directorate Change
09 Jul 2008 03:45 PM
RNS
Statement re. Suspension
01 Jul 2008 04:39 PM
RNS
Directorate Change
26 Jun 2008 12:27 PM
RNS
Change of Broker
25 Jun 2008 07:00 AM
RNS
Three Repeat Business Agreeme
19 Jun 2008 07:00 AM
RNS
Corporate update
14 May 2008 07:00 AM
RNS
Restructuring
02 May 2008 07:01 AM
RNS
Strategic Review
24 Apr 2008 11:07 AM
RNS
Notification of Shareholder
14 Apr 2008 09:26 AM
RNS
Fundraising
10 Apr 2008 07:01 AM
RNS
Presentation at AACR
31 Mar 2008 07:00 AM
RNS
Extension of Collaboration
06 Mar 2008 07:01 AM
RNS
Research Update
06 Mar 2008 07:00 AM
RNS
Interim Results
04 Feb 2008 07:00 AM
RNS
Notice of Results
12 Dec 2007 07:01 AM
RNS
Genentech Agreement
30 Nov 2007 07:00 AM
RNS
Total Voting Rights
19 Nov 2007 07:00 AM
RNS
Director/PDMR Shareholding
16 Nov 2007 07:01 AM
RNS
Board Appointment
15 Nov 2007 03:07 PM
RNS
Placing of Shares
15 Nov 2007 12:59 PM
RNS
AGM Statement
31 Oct 2007 03:58 PM
RNS
Total Voting Rights
26 Oct 2007 04:35 PM
RNS
Director/PDMR Shareholding
24 Oct 2007 12:24 PM
RNS
Placing of shares
22 Oct 2007 07:01 AM
RNS
Fundraising
16 Oct 2007 04:33 PM
RNS
Annual Report and AGM notice
08 Oct 2007 11:01 AM
RNS
Holding(s) in Company
02 Oct 2007 07:01 AM
RNS
Research Update
02 Oct 2007 07:01 AM
RNS
Preliminary Results
21 Sep 2007 07:01 AM
RNS
Directorate Change
13 Sep 2007 09:42 AM
RNS
Notice of Results
16 Aug 2007 07:00 AM
RNS
Disclosure of Information
30 Jul 2007 07:02 AM
RNS
Extention of Collaboration
18 Jun 2007 12:34 PM
RNS
Directorate Change
15 May 2007 07:00 AM
RNS
Cancer Program Update
06 Feb 2007 07:01 AM
RNS
Research Programme Update
06 Feb 2007 07:00 AM
RNS
Interim Results
31 Jan 2007 11:08 AM
RNS
Total Voting Rights
22 Jan 2007 07:00 AM
RNS
Collaboration with J&J
12 Jan 2007 07:00 AM
RNS
Notice of Results & Update
08 Jan 2007 07:00 AM
RNS
New Investment in Sareum

Sareum Holdings Plc (Sareum) is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor Library (SKIL). The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. Its research programs include Chk1 (checkpoint kinase 1), Aurora+FLT3 kinase, Autoimmune-TYK2/JAK1 kinases, and Cancer-TYK2/JAK1 kinases. Sareum's Chk1 kinase cancer research program is being conducted through joint research collaboration with Cancer Research Technology Limited and the Institute of Cancer Research. Sareum is headquartered in Cambridge, the UK.

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings